Alberto Gonzalez-Gonzalez

Mr. Alberto Gonzalez-Gonzalez

Universidad de Cantabria – IDIVAL, Santander, Spain
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2020 in World Journal of Stem Cells
Verified
Journal Article
Open access
Alberto Gonzalez-GonzalezAlberto Gonzalez-Gonzalez
Alberto Gonzalez-Gonzalez
DGDaniel García-Sánchez
Daniel García-Sánchez
MDMonica Dotta
Monica Dotta
JRJosé C Rodríguez-Rey
José C Rodríguez-Rey
FCFLOR MARIA PEREZ CAMPO
FLOR MARIA PEREZ CAMPO
Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine

Verified
Journal Article
Open access
PDF file
CECristina Blanco Elices
Cristina Blanco Elices
Jesus Chato-AstrainJesus Chato-Astrain
Jesus Chato-Astrain
Alberto Gonzalez-GonzalezAlberto Gonzalez-Gonzalez
Alberto Gonzalez-Gonzalez
DSDavid Sanchez-Porras
David Sanchez-Porras
Víctor CarrielVíctor Carriel
Víctor Carriel
IGIngrid J. Garzón
Ingrid J. Garzón
The embryonic development of the human umbilical cord (hUC) is complex, and different regions can be identified in this structure. The aim of this work is to characterize the hUC at in situ and ex vivo levels to stablish their potential use in vascular regeneration. Human umbilical cords were obtained and histologically prepared for in the situ analysis of four hUC regions (intervascular—IV, perivascular—PV, subaminoblastic—SAM, and Wharton’s jelly—WH), and primary cell cultures of mesenchymal stem cells (hUC-MSC) isolated from each region were obtained. The results confirmed the heterogeneity of the hUC, with the IV and PV zones tending to show the higher in situ expression of several components of the extracellular matrix (collagens, proteoglycans, and glycosaminoglycans), vimentin, and MSC markers (especially CD73), although isolation and ex vivo culture resulted in a homogeneous cell profile. Three vascular markers were positive in situ, especially vWF, followed by CD34 and CD31, and isolation and culture revealed that the region associated with the highest expression of vascular markers was IV, followed by PV. These results confirm the heterogeneity of the hUC and the need for selecting cells from specific regions of the hUC for particular applications in tissue engineering.

17 August 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DSDaniel García Sánchez
Daniel García Sánchez
Alberto Gonzalez-GonzalezAlberto Gonzalez-Gonzalez
Alberto Gonzalez-Gonzalez
PGPatricia García García
Patricia García García
Ricardo ReyesRicardo Reyes
Ricardo Reyes
MNMaría Isabel Pérez Núñez
María Isabel Pérez Núñez
FCFLOR MARIA PEREZ CAMPO
FLOR MARIA PEREZ CAMPO
Mesenchymal stem cell (MSC) transplantation has emerged as a promising approach for bone regeneration. Importantly, the beneficial effects of MSCs can be improved by modulating the expression levels of specific genes to stimulate MSC osteogenic differentiation. We have previously shown that Smurf1 silencing by using Locked Nucleic Acid-Antisense Oligonucleotides, in combination with a scaffold that sustainably releases low doses of BMP-2, was able to increase the osteogenic potential of MSCs in the presence of BMP-2 doses significantly smaller than those currently used in the clinic. This would potentially allow an important reduction in this protein in MSs-based treatments, and thus of the side effects linked to its administration. We have further improved this system by specifically targeting the Wnt pathway modulator Sfrp1. This approach not only increases MSC bone regeneration efficiency, but is also able to induce osteogenic differentiation in osteoporotic human MSCs, bypassing the need for BMP-2 induction, underscoring the regenerative potential of this system. Achieving successful osteogenesis with the sole use of LNA-ASOs, without the need of administering pro-osteogenic factors such as BMP-2, would not only reduce the cost of treatments, but would also open the possibility of targeting these LNA-ASOs specifically to MSCs in the bone marrow, allowing us to treat systemic bone loss such as that associated with osteoporosis.

Verified
Journal Article
Open access
PDF file
IÁItziar Álvarez-Iglesias
Itziar Álvarez-Iglesias
ACAlice Colombo
Alice Colombo
LGLuis Gil-de-Gómez
Luis Gil-de-Gómez
DSDaniel García Sánchez
Daniel García Sánchez
Alberto Gonzalez-GonzalezAlberto Gonzalez-Gonzalez
Alberto Gonzalez-Gonzalez
FCFLOR MARIA PEREZ CAMPO
FLOR MARIA PEREZ CAMPO
Bone homeostasis and regeneration depend on tightly regulated interactions between skeletal cells and the immune system within the bone microenvironment. Disruption of this crosstalk by ageing, chronic inflammation, or systemic disease contributes to osteoporosis, inflammatory bone loss, and impaired fracture healing. Osteoimmunology has reframed bone biology as an immune-regulated process, highlighting mesenchymal stem cells (MSCs) as central coordinators of bone-immune communication. Beyond their differentiation capacity, MSCs act primarily through paracrine mechanisms, releasing a secretome composed of soluble factors and extracellular vesicles (EVs) that modulate immune responses, regulate osteoblast and osteoclast activity, promote angiogenesis, and support extracellular matrix remodelling. MSC-derived EVs have emerged as key nanoscale mediators that transfer bioactive cargo to target cells in a context-dependent manner, enabling precise regulation of osteoimmune processes. This review summarises current knowledge on the role of MSCs in osteoimmunology, with a focus on how their secretome and EVs integrate immune modulation with bone regeneration. We discuss the mechanisms underlying MSC-mediated regulation of innate and adaptive immune cells, examine emerging cell-free therapeutic strategies based on secretome and EV delivery, and outline the main challenges that must be addressed to advance these approaches towards clinical application.

Verified
Journal Article
Open access
PDF file
DSDaniel García Sánchez
Daniel García Sánchez
Alberto Gonzalez-GonzalezAlberto Gonzalez-Gonzalez
Alberto Gonzalez-Gonzalez
IÁItziar Álvarez-Iglesias
Itziar Álvarez-Iglesias
MDMónica del Dujo-Gutiérrez
Mónica del Dujo-Gutiérrez
ABAlfonso Bolado-Carrancio
Alfonso Bolado-Carrancio
FCFLOR MARIA PEREZ CAMPO
FLOR MARIA PEREZ CAMPO
The evidence sustaining the regenerative properties of mesenchymal stem cells’ (MSCs) secretome has prompted a paradigm change, where MSCs have shifted from being considered direct contributors to tissue regeneration toward being seen as cell factories for producing biotech medicines. We have previously designed a method to prime MSCs towards osteogenic differentiation by silencing the Wnt/β-Catenin inhibitor Sfpr1. This approach produces a significant increase in bone formation in osteoporotic mice. In this current work, we set to investigate the contribution of the secretome from the MSCs where Sfrp1 has been silenced, to the positive effect seen on bone regeneration in vivo. The conditioned media (CM) of the murine MSCs line C3H10T1/2, where Sfrp1 has been transiently silenced (CM-Sfrp1), was found to induce, in vitro, an increase in the osteogenic differentiation of this same cell line, as well as a decrease of the expression of the Wnt inhibitor Dkk1 in murine osteocytes ex vivo. A reduction in the RANKL/OPG ratio was also detected ex vivo, suggesting a negative effect of CM-Sfrp1 on osteoclastogenesis. Moreover, this CM significantly increases the mineralization of human primary MSCs isolated from osteoportotic patients in vitro. Proteomic analysis identified enrichment of proteins involved in osteogenesis within the soluble and vesicular fractions of this secretome. Altogether, we demonstrate the pro-osteogenic potential of the secretome of MSCs primmed in this fashion, suggesting that this is a valid approach to enhance the osteo-regenerative properties of MSCs’ secretome.

8 November 2022
Verified
Book Chapter
Closed access
PDF file
Alberto Gonzalez-GonzalezAlberto Gonzalez-Gonzalez
Alberto Gonzalez-Gonzalez
DSDaniel García Sánchez
Daniel García Sánchez
AAAna Alfonso-Fernández
Ana Alfonso-Fernández
KHKhawaja Husnain Haider
Khawaja Husnain Haider
JRJose Rodríguez-Rey
Jose Rodríguez-Rey
FCFLOR MARIA PEREZ CAMPO
FLOR MARIA PEREZ CAMPO